Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Topical Pain Relief Market By Therapeutic Class (Non-Opioids, Opioids), By Type (Prescription Pain Relief, Over-the-counter (OTC) Pain Relief), By Formulation (Cream, Gel, Spray, Patch), By Distribution Channel (Pharmacies & Drug Stores, E-Commerce) - Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Topical Pain Relief Market was valued at USD 7,648 Million in the year 2017. Global Topical Pain Relief market is further estimated to grow at a CAGR of 7.34% from 2018 to reach USD 11,698 Million by the year 2023.

North America region holds the highest market share and Asia Pacific is considered as the fastest growing market in the forecasted period. At the country level, U.S, China and Japan are considered to be the fastest growing market in the coming years owning to high disposable income and growing healthcare industry.

The key manufacturers of topical pain relief products taken in the report are GlaxoSmithKline plc. (U.K), Johnson & Johnson (U.S), Pfizer Inc. (U.S), AdvaCare Pharma (Shanghai),Novartis AG (Switzerland), Nestlé S.A. (Switzerland),Sanofi (France), Sun Pharmaceutical Industries Ltd. (India), Topical BioMedics, Inc. (U.S), and Reckitt Benckiser Group plc (U.K).

Drivers:

Growing prevalence of arthritis and bone related health problems

Growing old age population

Restraints:

            Various side effects associated by using pain relief products

Opportunities:

            Growing demand in sports and athletic players

            Growing awareness of online pharmacy

Challenges:

            Availability of alternative pain management therapies

The global topical pain relief market is segmented based on therapeutic class, type, formulation, distribution channel, and region. On the basis of therapeutic class, the market is segmented into non-opioids and opioids, of these opioids segment accounts for the largest market share and is projected to grow at a moderate CAGR of XX%.

By type, the topical pain relief market is segmented into prescription pain relief and over-the-counter (OTC) relief. Over-the-counter pain relief segment accounted for the largest market share in 2017 due to easy availability and high demand of topical pain relief products by sportsperson. By distribution channel, the market is segmented into pharmacies & drug stores, e-commerce, and retail & grocery stores.

Key Benefits for Stakeholders

Topical Pain Relief manufacturers

Pharmaceutical and healthcare companies

Healthcare Research and associations

Government & Regulatory agencies and organizations

By Therapeutic Class

Non-Opioids

            Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)

            Methyl Salicylate

            Capsaicin

            Lidocaine

            Other Non-opioids

Opioids

            Buprenorphine

            Fentanyl

By Type

Prescription Pain Relief

Over-the-counter (OTC) Pain Relief

By Formulation

Cream

Gel

Spray

Patch

Others

By Distribution Channel

Pharmacies & Drug Stores

E-Commerce

Retail & Grocery Stores

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

GlaxoSmithKline plc.

Johnson & Johnson

Pfizer Inc.

AdvaCare Pharma

Novartis AG

Nestlé S.A.

Sanofi

Sun Pharmaceutical Industries Ltd.

Topical BioMedics, Inc.

Reckitt Benckiser Group plc

(A brief overview of 10 companies is also provided in the report.)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.

Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Topical Pain Relief Market, By Therapeutic Class

6.1 Non-Opioids

            6.1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)

            6.1.2 Methyl Salicylate

            6.1.3 Capsaicin

            6.1.4 Lidocaine

            6.1.5 Other Non-opioids

6.2 Opioids

            6.2.1 Buprenorphine

            6.2.2 Fentanyl

7. Topical Pain Relief Market, By Type

7.1 Prescription Pain Relief

7.2 Over-the-counter (OTC) Pain Relief

8. Topical Pain Relief Market, By Formulation

8.1 Cream

8.2 Gel

8.3 Spray

8.4 Patch

8.5 Others

9. Topical Pain Relief Market, By Distribution Channel

9.1 Pharmacies & Drug Stores

9.2 E-Commerce

9.3 Retail & Grocery Stores

10. Geographical Analysis

10.1. Introduction

10.2. North America

       10.2.1. U.S.

       10.2.2. Canada

       10.2.3. Mexico

10.3. Europe

       10.3.1. U.K.

       10.3.2. Germany

       10.3.3. France

       10.3.4. RoE

10.4. Asia Pacific

       10.4.1. South Korea

       10.4.2. China

       10.4.3. Japan

       10.4.4. RoAPAC

10.5. RoW

       10.5.1. Latin America

       10.5.2. Middle East and Africa

11. Company Profiles

(Business Overview, Financial Overview, Product write up, Recent Developments)

11.1 GlaxoSmithKline plc.

11.2 Johnson & Johnson

11.3 Pfizer Inc.

11.4 AdvaCare Pharma

11.5 Novartis AG

11.6 Nestlé S.A.

11.7 Sanofi

11.8 Sun Pharmaceutical Industries Ltd.

11.9 Topical BioMedics, Inc.

11.10 Reckitt Benckiser Group plc

(A brief overview of 10 companies is also provided in the report.)

12. Competitive Analysis

12.1. Introduction

12.2. Market Positioning of Key Players

12.3 Competitive Strategies Adopted by Leading Players

        12.3.1. Investments & Expansions

        12.3.2. New Product Launches

        12.3.3. Mergers & Acquisitions

        12.3.4. Agreements, Joint Ventures, and Partnerships

13. Appendix

13.1. Questionnaire

13.2. Available Customizations 

13.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

* The list of tables and figures will be provided in the sample report.

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports